Litigation Details for Otsuka Pharmaceutical Co. Ltd. v. Par Pharmaceutical Inc. (D. Del. 2014)

Otsuka Pharmaceutical Co. Ltd. v. Par Pharmaceutical Inc. (D. Del. 2014)

Docket		Date Filed	2014-06-20
Court	District Court, D. Delaware	Date Terminated	2015-09-23
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Patents	8,501,730
Link to Docket	External link to docket

Details for Otsuka Pharmaceutical Co. Ltd. v. Par Pharmaceutical Inc. (D. Del. 2014)

Date Filed	Document No.	Description	Snippet	Link To Document
2014-06-20	1		United States Patent Nos. 5,753,677 (“the ’677 patent”) and 8,501,730 (“the ’730 patent”). This action…assignee of the ’677 patent. The ’677 patent expires in 2020. 9. The ’677 patent is listed in the… of the ’730 patent. The ’730 patent expires in 2026. 11. The ’730 patent is listed in the… The ’677 Patent 8. The ’677 patent, entitled “Benzoheterocyclic Compounds…correct copy of the ’677 patent is attached hereto as Exhibit A. The ’677 patent claims methods for antagonizing	External link to document
2014-06-20	4		Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,753,677; 8,501,730 B2. (snb, ) (… 23 September 2015 1:14-cv-00789 830 Patent None District Court, D. Delaware	External link to document
2015-04-10	47		Initial Invalidity Contentions for U.S. Patent No. 8,501,730 filed by Par Pharmaceutical Inc..(Lester… 23 September 2015 1:14-cv-00789 830 Patent None District Court, D. Delaware	External link to document
2015-09-23	63		Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,753,677; 8,501,730 B2. (Attachments… 23 September 2015 1:14-cv-00789 830 Patent None District Court, D. Delaware	External link to document